comprehensive -WSS

comprehensive

author：leisure time 2025-08-26 23:47:40 - browse：42

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Neuroscience’s long legacy of racism

WSS

The SUPPORT Act is critical to fighting the opioid crisis

Argenx readies a blockbuster opportunity with drug for autoimmune disease

UnitedHealth increases loan offers after Change Healthcare outage

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

5 to watch: Tech startups trying to solve health care's staffing crisis

Argenx readies a blockbuster opportunity with drug for autoimmune disease

explore

comprehensive

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Moonlake's readout produced a cash windfall. Risks remain

Intermittent fasting comes with a heart risk? Not so fast

Malaria cases in Florida and Texas: Here’s what you need to know

Colonoscopy prep: Liquid

State Dept. review finds Biden bears some blame for Afghanistan failures

AstraZeneca to buy developer of next

Anesthesiologist group: stop taking Ozempic before surgery

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Wikipedia

GSK to buy asthma

Virtual Event: March of the Biosimilars

Nurses recount patients attacks

Gene editing the human germline: What are the risks?

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Leading voice in opioid treatment defends methadone clinic system

explore

hotspot

focus

hotspot